Immunic IMUX Investor Presentation August 2024

Immunic Inc. is developing a pipeline of next-generation selective oral therapies for chronic inflammatory and autoimmune diseases. The presentation outlines the company's strategy, clinical programs, and commercialization plans for immunology-focused treatment options.